Fact CheckerSign in

NCT06295406Completed

Reading Ability in Childhood Obesity

Source: ClinicalTrials.gov · Last updated 26 Aug 2025

Brief summary (registry, in English)

There is some evidence about the negative impact of overweight and obesity on reading ability, with negative consequences on quality of life and school success. In this neuropsychological research, the relationship between the characteristics of reading abilities in individuals with obesity (age range between 11 and 16 years) and the skills of motor coordination, postural stability, manual dexterity, including graphomotor skills, and estimation of time is investigated according to the cerebellar deficit theory.

Status (registry)
Completed
Study type
Observational
Enrollment
30 (actual)
First submitted
28 Feb 2024
Start date
1 Dec 2023
Primary completion date
30 Dec 2024
Lead sponsor
Istituto Auxologico Italiano
Diseases
Obesity
NCT number
NCT06295406

What you commit to

  • Study type: Observational
  • Participants enrolled: 30
  • From 1 Dec 2023 to the primary completion date, 30 Dec 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • concurrent neurological, neurodevelopmental (e.g., autism), motor, somatosensory and/or psychiatric disorders.

Who the study is looking for

  • diagnosis of overweight or obesity

Age in the registry: 11 years to 16 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
IRCCS Istituto Auxologico Italiano - Ospedale San Giuseppe
Coordinator of this site? Confirm its status
PiancavalloItalyUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.